TILs are lymphocytes isolated from tumor tissues and mainly include CD3+ T cells, CD4+ T cells, and CD8+ T cells, especially CD8+ T cells, which are the basis for producing an effect of immunotherapy (51). Here, CD4 is linked to neoplasm.